ONCTERNAL THERAPEUTICS INC's ticker is ONCT and the CUSIP is 68236P107. A total of 27 filers reported holding ONCTERNAL THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43,330 | -13.0% | 144,434 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $49,830 | -56.1% | 144,434 | 0.0% | 0.00% | -66.7% |
| Q1 2023 | $113,381 | -21.5% | 144,434 | 0.0% | 0.00% | -25.0% |
| Q4 2022 | $144,434 | +12.0% | 144,434 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $129,000 | -19.4% | 144,434 | 0.0% | 0.00% | -20.0% |
| Q2 2022 | $160,000 | -20.4% | 144,434 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $201,000 | +22.6% | 144,434 | +100.0% | 0.01% | +25.0% |
| Q4 2021 | $164,000 | -45.5% | 72,217 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $301,000 | -12.2% | 72,217 | 0.0% | 0.01% | -20.0% |
| Q2 2021 | $343,000 | -42.9% | 72,217 | 0.0% | 0.01% | -60.0% |
| Q1 2021 | $601,000 | +69.8% | 72,217 | 0.0% | 0.02% | +56.2% |
| Q4 2020 | $354,000 | +187.8% | 72,217 | 0.0% | 0.02% | +128.6% |
| Q3 2020 | $123,000 | -40.0% | 72,217 | 0.0% | 0.01% | -46.2% |
| Q2 2020 | $205,000 | -3.3% | 72,217 | 0.0% | 0.01% | -23.5% |
| Q1 2020 | $212,000 | – | 72,217 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 360,000 | $1,501,000 | 0.78% |
| Parkman Healthcare Partners LLC | 325,384 | $1,357,000 | 0.34% |
| Vigilare Wealth Management | 63,460 | $265,000 | 0.16% |
| BRIGHTON JONES LLC | 333,875 | $1,392,000 | 0.07% |
| HighVista Strategies LLC | 23,121 | $97,000 | 0.06% |
| Ikarian Capital, LLC | 199,180 | $830,000 | 0.06% |
| Total Clarity Wealth Management, Inc. | 26,430 | $110,000 | 0.05% |
| IPG Investment Advisors LLC | 30,756 | $128,253,000 | 0.04% |
| DOWLING & YAHNKE LLC | 150,464 | $627,000 | 0.04% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 22,015 | $92,000 | 0.01% |